Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study

PURPOSE: The purpose of this study was to assess the potential benefit of a 5-hydroxytryptamine receptor antagonist, sarpogrelate-based triple antiplatelet therapy (TAPT) in comparison with dual antiplatelet therapy (DAPT) in patients undergoing primary percutaneous coronary intervention (PCI) for S...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae Hyuk, Cho, Jung Rae, Park, Sang Min, Shaha, Kunal Bikram, Pierres, Floyd, Sumiya, Tserendavaa, Chun, Kwang Jin, Kang, Min-Kyung, Choi, Seonghoon, Lee, Namho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552650/
https://www.ncbi.nlm.nih.gov/pubmed/28792139
http://dx.doi.org/10.3349/ymj.2017.58.5.959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552650/
https://www.ncbi.nlm.nih.gov/pubmed/28792139
http://dx.doi.org/10.3349/ymj.2017.58.5.959

Ejemplares similares